Is safe supply for opioid use effective? Here’s what the experts, data say – National

Is safe supply for opioid use effective? Here’s what the experts, data say – National

Front-line staff of Canada’s opioid crisis say damage reduction approaches like safe materials for those people navigating compound use are clear even amid renewed political debate close to the difficulty.

Debate all-around risk-free offer a short while ago reignited right after Conservative Party Leader Pierre Poilievre posted a video to his Twitter account saying initiatives like harmless intake websites and supplying a safer offer of medications to persons in the throes of habit “will only guide to their ultimate fatalities.”

Browse extra:

Amid grim opioid dying projections, Ottawa faces phone calls to move quicker on safe and sound provide

World News spoke to specialists who have been functioning on the frontlines of the opioid crisis to hear their experiences, and all those who weighed in voiced issues. A rising overall body of information, specialists instructed, indicates initiatives like risk-free provide and hurt reduction really decrease overdose fatalities and hospitalizations and help connect people to more health treatment and treatment selections.

Story carries on beneath advertisement

“To describe harmless supply as producing homelessness, as producing an enhance in criminal offense is genuinely just the reverse of what we’re seeing from the investigation alone,” claimed Mish Waraksa, medical guide for the Parkdale Queen West Safer Opioid Supply Application in Toronto.

Here’s what the info and experts say about the usefulness of safe offer.

The video, “Everything is damaged,” was shared in November on the Conservative leader’s Twitter account.

It shows Poilievre in the foreground, pointing behind him to a collection of tents along a shoreline in Vancouver, B.C., saying the people today in the tents are “hopelessly addicted to drugs, placing poisons in their bodies.”

“The addictions that we see, that have terrorized these folks and our communities, they are the result of a failed experiment,” Poilievre says in the video.

Story proceeds under advertisement

“This is a deliberate policy by woke Liberal and NDP governments to provide taxpayer-funded medications, flood our streets with easy accessibility to these poisons.”

The video clip drew criticism from many in Canada’s political realm, like a former adviser to former Conservative key minister Stephen Harper, Ben Perrin, who mentioned it reflected “tropes that have prolonged been discredited.”

Examine more:

Safe use forefront of countering the overdose disaster, prime minister claims

Federal Mental Health and fitness and Addictions Minister Carolyn Bennett, known as the video “irresponsible.”

“Using (people dwelling in tents) as props to peddle his snake oil was disgraceful,” Bennett mentioned at a Residence of Commons committee meeting on Nov. 29, stressing that all federally-funded harm reduction initiatives are rooted in proof-dependent results.

“This is about generating a community of compassion… this is about the poisonous drug provide, but (also) it’s understanding dependancy.”

A request for remark from Poilievre for this story went unanswered.

Hunting at the knowledge on opioid fatalities does paint a grim photo of the deadly and developing toll the opioid disaster is getting on Canadians.

Story proceeds down below ad

A full of 29,052 Canadians have died due to opioids due to the fact 2016, according to the most current federal data released in June.

In 2021, the amount of deaths reached an all-time significant: 21 Canadians for every day died from opioids, which represents a 162 per cent raise from 2016, and a 101 for every cent raise from the year prior to.

A complete of 7,560 Canadians died from opioid use very last yr, up from 3,747 in 2020.

Even though these data are sobering, there is also facts to propose some hurt reduction steps that have been executed are saving lives.

For illustration, supervised usage web pages across the region been given almost 2.2 million visits amongst 2017 and 2020, where by nearly 17,400 overdoses have been reversed devoid of a single loss of life at a web site, federal information reveals.


Click to play video: 'Advocates say Alberta should revisit safe supply in light of new research'


Advocates say Alberta should revisit risk-free offer in gentle of new investigate


These visits also led to about 84,400 referrals to wellness and social companies.

Tale continues below advertisement

And when it comes to safer supply plans, exactly where people are given access to prescriptions of pharmaceutical-grade opioids, some new scientific studies have also revealed positive outcomes.

A assessment of 10 federally-funded safer supply pilot assignments in three provinces, commissioned by Well being Canada and unveiled previously this year, cited members reporting advancements in their life and well-getting.

Purchasers claimed having entry to a safer provide of medication saved their lives, designed much more security, allowed them to turn into housed and used and gave them hope for their foreseeable future.

A different impartial research published in September in the Canadian Health-related Affiliation Journal (CMAJ) discovered protected opioid provide packages can appreciably lower down on crisis office visits and hospitalizations for persons at substantial hazard for overdose.

Go through a lot more:

Safer opioid provide program potential customers to fall in Ontario hospitalizations, ER visits: study

That review seemed at men and women who utilized a safer source program in London, Ont., for a few years, and located ER visits and healthcare facility admissions declined a person year after participants entered the plan.

It also observed no elevated risk of bacterial infections or overdoses and a drop in wellness-treatment prices unrelated to major care or outpatient remedies following a calendar year.

In addition, there ended up no opioid-connected deaths among the individuals who ended up part of this software.

Story proceeds beneath ad


Click to play video: 'Safe drug supply key recommendation in reducing toxic illicit drug-related deaths'


Secure drug offer critical suggestion in decreasing poisonous illicit drug-related fatalities


Why are opioid fatalities still rising?

The greatest driver of the overdose disaster in Canada considering that 2016 is the contamination of the street drug supply with more powerful medication like fentanyl, states Cheyanne Johnson, executive director at the B.C. Middle on Compound Use. 

But this has also shifted in excess of time, notably accelerating as a problem throughout the pandemic, when closed borders and suspended treatment programs triggered even far more contamination and overdoses, she claimed.

Tale carries on down below advertisement

For example, preliminary information for 2022 launched by the B.C. Coroner’s Company has located that fentanyl or similar medicine have been detected in 81 for every cent of all illicit drug toxicity fatalities in that province.

Even though Poilievre contrasted statistics on opioid use towards knowledge from just before 2015, which is when the Liberals gained govt, Johnson stated the distribute of fentanyl has altered the realities on the ground.

Examine a lot more:

New analyze highlights efficiency of Halifax protected offer drug software

“It’s very tough to compare pre-2015 stages of overdose to what is going on now mainly because the supply chain has thoroughly transformed,” she reported.

Blaming damage reduction systems that have reversed overdoses and that present access to medicines that are not “poisoned” shows a misunderstanding of the realities of this disaster, claimed Rob Boyd, CEO of Ottawa Internal City Health, which runs a safer supply program and other harm reduction initiatives.

Virtually any entrance-line worker who supports applications for drug customers would concur with Poilievre that far more funding is necessary for detox and in-individual rehabilitation therapy systems, he said.

But it doesn’t have to be a binary choice of “either” remedy systems “or” damage reduction initiatives like safer offer, he mentioned.

Lower-barrier applications that really do not call for comprehensive abstinence have established helpful at serving to persons who may possibly not if not be able to receive enable, Boyd explained.

Tale proceeds down below ad

Read through additional:

A lot more medical doctors are prescribing opioids to avoid their individuals from dying of overdoses

“That is way too substantial a threshold for any person who is injecting fentanyl five or 6 situations a day. We have to be equipped to start off conceptualizing treatment, commencing where by people today are at,” he mentioned.

“In some instances, safer provide can be a treatment for somebody since it delivers them a little bit of steadiness in that moment or in that working day in their lives.”

Due to the fact most safer supply pilot programs throughout Canada have wraparound supports, these kinds of as housing, wellbeing and social supports, clients who regularly get non-toxic medicines can slowly raise their ability and commitment for change, he stated.

Waraksa echoed this, indicating safer offer “keeps people alive until they are capable to accessibility other varieties of treatment.”

Over-all, Johnson states she finds it “disheartening” to see the opioid disaster remaining politicized.

“It really even further stigmatizes them and generates much more disgrace all around substance use.”

A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial | BMC Medicine

A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial | BMC Medicine
  • Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76.

    Article 
    PubMed 

    Google Scholar
     

  • Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:j4792.

    Article 
    PubMed 

    Google Scholar
     

  • Hirschfeld DJ. Trump Declares Opioid Crisis a ‘Health Emergency’ Requests no Funds The New York Times; 2017.


    Google Scholar
     

  • Hollmann MW, Rathmell JP, Lirk P. Optimal postoperative pain management: redefining the role for opioids. Lancet. 2019;393(10180):1483–5.

    Article 
    PubMed 

    Google Scholar
     

  • Silva BM, Rodrigues JJ, de la Torre DI, Lopez-Coronado M, Saleem K. Mobile-health: A review of current state in 2015. J Biomed Inform. 2015;56:265–72.

    Article 
    PubMed 

    Google Scholar
     

  • Bhavnani SP, Narula J, Sengupta PP. Mobile technology and the digitization of healthcare. Eur Heart J. 2016;37(18):1428–38.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017;152(6):e170504.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hamnvik OR, Alford DP, Ryan CT, Hardesty IT, Drazen JM. NEJM Knowledge+ Pain Management and Opioids – A New Adaptive Learning Module. N Engl J Med. 2019;380(16):1576–7.

    Article 
    PubMed 

    Google Scholar
     

  • Babu KM, Brent J, Juurlink DN. Prevention of Opioid Overdose. N Engl J Med. 2019;380(23):2246–55.

    Article 
    PubMed 

    Google Scholar
     

  • Colloca L, Barsky AJ. Placebo and Nocebo Effects. N Engl J Med. 2020;382(6):554–61.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Benedetti F. Placebo analgesia. Neurol Sci. 2006;27(2):100–2.

    Article 

    Google Scholar
     

  • Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol. 2004;3(11):679–84.

    Article 
    PubMed 

    Google Scholar
     

  • Hack TF, Degner LF, Parker PA, Team SC. The communication goals and needs of cancer patients: a review. Psychooncology. 2005;14(10):831–47.

    Article 
    PubMed 

    Google Scholar
     

  • Del Re AC, Fluckiger C, Horvath AO, Symonds D, Wampold BE. Therapist effects in the therapeutic alliance-outcome relationship: a restricted-maximum likelihood meta-analysis. Clin Psychol Rev. 2012;32(7):642–9.

    Article 
    PubMed 

    Google Scholar
     

  • Epstein R, Street RL. Patient-centered communication in cancer care: promoting healing and reducing suffering: National Cancer Institute. Bethesda: US Department of Health and Human Services, National Institutes of Health; 2007.


    Google Scholar
     

  • Baker PN, van der Meulen JH, Lewsey J, Gregg PJ. The role of pain and function in determining patient satisfaction after total knee replacement. Data from the National Joint Registry for England and Wales. J Bone Joint Surg Br. 2007;89(7):893–900.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • World Health O. ICD-10 : international statistical classification of diseases and related health problems : tenth revision. 2nd ed. Geneva: World Health Organization; 2004.


    Google Scholar
     

  • Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9(6):767–76.

    Article 
    PubMed 

    Google Scholar
     

  • Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60.

    Article 
    PubMed 

    Google Scholar
     

  • Booth RG, Strudwick G, McBride S, O’Connor S, Solano López AL. How the nursing profession should adapt for a digital future. BMJ. 2021;373:n1190.

    Article 
    PubMed Central 

    Google Scholar
     

  • Fairbrother P, Ure J, Hanley J, McCloughan L, Denvir M, Sheikh A, et al. Telemonitoring for chronic heart failure: the views of patients and healthcare professionals – a qualitative study. J Clin Nurs. 2014;23(1-2):132–44.

    Article 
    PubMed 

    Google Scholar
     

  • Barello S, Triberti S, Graffigna G, Libreri C, Serino S, Hibbard J, et al. eHealth for Patient Engagement: A Systematic Review. Front Psychol. 2015;6:2013.

    PubMed 

    Google Scholar
     

  • Eaton L, Walsh C, Magnuson T, Schweitzer M, Lidor A, Nguyen H, et al. On-line bariatric surgery information session as effective as in-person information session. Surg Obes Relat Dis. 2012;8(2):225–9.

    Article 
    PubMed 

    Google Scholar
     

  • Heikkinen K, Leino-Kilpi H, Vahlberg T, Salanterä S. Ambulatory orthopaedic surgery patients’ symptoms with two different patient education methods. Int J Orthop Trauma Nurs. 2012;16(1):13–20.

    Article 

    Google Scholar
     

  • Matthew DA. The use of a computer website prior to scheduled surgery (a pilot study): impact on patient information, acquisition, anxiety level, and overall satisfaction with anesthesia care. AANA J. 2005;73(1):29.


    Google Scholar
     

  • D’Haese PF, Pallavaram S, Li R, Remple MS, Kao C, Neimat JS, et al. CranialVault and its CRAVE tools: a clinical computer assistance system for deep brain stimulation (DBS) therapy. Med Image Anal. 2012;16(3):744–53.

    Article 
    PubMed 

    Google Scholar
     

  • de Visser H, Watson MO, Salvado O, Passenger JD. Progress in virtual reality simulators for surgical training and certification. Med J Aust. 2011;194(4):S38–40.

    PubMed 

    Google Scholar
     

  • Neuprez A, Neuprez AH, Kaux J-F, Kurth W, Daniel C, Thirion T, et al. Early Clinically Relevant Improvement in Quality of Life and Clinical Outcomes 1 Year Postsurgery in Patients with Knee and Hip Joint Arthroplasties. Cartilage. 2018;9(2):127–39.

    Article 
    PubMed 

    Google Scholar
     

  • Klimek M, Büchele G, Rehm M, Beyersmann J, Günther KP, Brenner H, et al. Long-term mortality of patients with osteoarthritis after joint replacement: Prognostic value of pre-and postoperative pain and function. Athritis Care Res. 2021;0(0):1–7. https://doi.org/10.1002/acr.24808.

    Article 
    CAS 

    Google Scholar
     

  • Kaptchuk TJ, Miller FG. Placebo Effects in Medicine. N Engl J Med. 2015;373(1):8–9.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90(3):205–15.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3(70):70ra14. https://doi.org/10.1126/scitranslmed.3001244.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014;6(218ra5).

  • Levine JD, Gordon NC. Influence of the method of drug administration on analgesic response. Nature. 1984;312(5996):755–6.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Moore RA, Cai N, Skljarevski V, Tolle TR. Duloxetine use in chronic painful conditions–individual patient data responder analysis. Eur J Pain. 2014;18(1):67–75.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord. 2009;118(1-3):1–8.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Colloca L. The Placebo Effect in Pain Therapies. Annu Rev Pharmacol Toxicol. 2019;59:191–211.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M, et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain. 2012;153(2):382–90.

    Article 
    PubMed 

    Google Scholar
     

  • Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5(12):e15591.

    Article 
    PubMed 
    PubMed Central 
    CAS 

    Google Scholar
     

  • Timmers T, Janssen L, Kool RB, Kremer JA. Educating Patients by Providing Timely Information Using Smartphone and Tablet Apps: Systematic Review. J Med Internet Res. 2020;22(4):e17342.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Klinger R, Colloca L, Bingel U, Flor H. Placebo analgesia: clinical applications. Pain. 2014;155(6):1055–8.

    Article 
    PubMed 

    Google Scholar
     

  • Colloca L, Jonas WB, Killen J, Miller FG, Shurtleff D. Reevaluating the placebo effect in medical practice. Z Psychol. 2014;222(3):124–7.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Benedetti F. Placebo Effects. Understanding the mechanisms in health and disease. Oxford: Oxford University Press; 2014.

    Book 

    Google Scholar
     

  • Colloca L, Miller FG. Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1922–30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12(3):191–204.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9(12):39–47.

    Article 
    PubMed 

    Google Scholar
     

  • Schedlowski M, Enck P, Rief W, Bingel U. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacol Rev. 2015;67(3):697–730.

    Article 
    PubMed 

    Google Scholar
     

  • Crum A, Zuckerman B. Changing Mindsets to Enhance Treatment Effectiveness. JAMA. 2017;317(20):2063–4.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–90.

    Article 
    PubMed 

    Google Scholar
     

  • Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain. 2005;114(1-2):3–6.

    Article 
    PubMed 

    Google Scholar
     

  • Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Colloca L. How do placebo effects and patient-clinician relationships influence behaviors and clinical outcomes? Pain Rep. 2019;4(3):e758.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ashton-James CE, Forouzanfar T, Costa D. The contribution of patients’ presurgery perceptions of surgeon attributes to the experience of trust and pain during third molar surgery. Pain Rep. 2019;4(3):e754.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Henry SG, Matthias MS. Patient-Clinician Communication About Pain: A Conceptual Model and Narrative Review. Pain Med. 2018;19(11):2154–65.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Volkow ND, Collins FS. The Role of Science in Addressing the Opioid Crisis. N Engl J Med. 2017;377(4):391–4.

    Article 
    PubMed 

    Google Scholar
     

  • White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11(6):469–79.

    Article 
    PubMed 

    Google Scholar
     

  • Wolford ML, Palso K, Bercovitz A. Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000-1010: US Department of Health and Human Services, Centers for Disease Control and …; 2015.

  • Arthrose K-IR. Gesundheitsberichterstattung des Bundes. Berlin: RKI; 2013.


    Google Scholar
     

  • Darley JM, Fazio RH. Expectancy confirmation processes arising in the social interaction sequence. Am Psychol. 1980;35(10):867–81.

    Article 

    Google Scholar
     

  • Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–49.

    Article 

    Google Scholar
     

  • Klinger R, Krug F, Goßmann M, Damzog U, Dahme B, Bruch H-P. Das perioperative Schmerz- und Befindlichkeitsinventar: Ein Fragebogen zur Erfassung der perioperativen Lebensqualität. Der Schmerz. 1999;13:86.


    Google Scholar
     

  • Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM. The applicability of the West Haven-Yale multidimensional pain inventory in German-speaking countries. Data on the reliability and validity of the MPI-D. Schmerz. 1990;4(2):82–7.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86–95.

    Article 
    PubMed 

    Google Scholar
     

  • Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol. 1997;24(4):779–81.

    PubMed 
    CAS 

    Google Scholar
     

  • Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.

    Article 
    PubMed 

    Google Scholar
     

  • Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2(1):e000435.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim SS, Kaplowitz S, Johnston MV. The effects of physician empathy on patient satisfaction and compliance. Eval Health Prof. 2004;27(3):237–51.

    Article 
    PubMed 
    CAS 

    Google Scholar
     

  • Sim I. Mobile Devices and Health. N Engl J Med. 2019;381(10):956–68.

    Article 
    PubMed 

    Google Scholar
     

  • Bortz J, Schuster C. Statistik für Human-und Sozialwissenschaftler: Limitierte Sonderausgabe. Berlin: Springer-Verlag; 2011.


    Google Scholar
     

  • The under-the-radar battle over opioid addiction treatment legislation

    The under-the-radar battle over opioid addiction treatment legislation

    Comment

    Good morning, Early Birds. Our colleague Paul Kane is looking to write a think piece about a mid-level congressman struggling with his or her own limitations in the harsh face of stardom. Whom should he profile? Tips: earlytips@washpost.com. Thanks for waking up with us.

    Programming note: Tune in to Washington Post Live at 9:30 a.m. Eastern time to watch Leigh Ann interview New Hampshire Gov. Chris Sununu (R) about his goals for his fourth term, the direction he’d like his party to move and his future.

    Reading this online? Sign up for The Early 202 to get scoops and sharp political analysis in your inbox each morning.

    In today’s edition …  Gun control groups are divided over whether the Senate should hold a vote during the lame duck on an assault weapons ban … What we’re watching: The Senate’s rail strike vote and a crypto hearing … Here’s how federal judges think about diversity in hiring law clerks … Where the House GOP Impeachment 10’s aides are landing … but first …

    The under-the-radar battle over opioid addiction treatment legislation

    In the final legislative sprint of the year, a quiet battle is being waged in Congress over how best to treat certain drug addictions, as the opioid epidemic continues to ravage parts of the country and deaths from overdoses remain historically high.

    In many ways, it is a classic Washington showdown: Lawmakers and certain advocates are pushing one policy, while an industry fights to keep it from being enacted.

    But the life-or-death nature of the opioid crisis and the destructive path it has cut through all manner of communities have lent an intensity to the debate that you don’t find in the push-and-pull over which corporate tax breaks should be extended.

    At issue is access to methadone as a treatment for opioid addiction and whether patients should have to show up at a treatment facility each day to receive their dose or if they can simply call their doctor. 

    Rep. Donald W. Norcross (D-N.J.) and Sen. Edward J. Markey (D-Mass.) are pushing legislation they introduced one year ago that would enable certified addiction-treatment physicians to prescribe methadone at a local pharmacy for stable patients who could then take the treatments at home. Certain patients would also be allowed to take home as much as a one-month supply of the medication.

    Most methadone treatment is required, by federal rulemaking, to take place at a certified opioid treatment facility, known as an OTP. But those rules were eased during the coronavirus pandemic. Norcross, Markey and their supporters argue this flexibility helped patients by making it easier to take the medication. Having to go to a clinic each day is difficult with work, child care, lack of transportation — and there is a stigma associated with going to one, they contend.

    Some people also don’t have easy access to an OTP: 24 percent of the population, or 77 million people, don’t have one in their county, according to a 2019 report by the Congressional Research Service. 

    “The idea of having to go to this one location to pick up your meds is just nuts,” Norcross said. 

    Ronnie Hartman, 33, can attest. He has been recovering from opioid addiction and using methadone for five years. He’s slowly weaning off the medication but said accessing his treatment makes the road to recovery more difficult. 

    “I know how hard it can be having to go to the clinic every day in order to get medication,” Hartman said. “It takes a lot of energy and time to get medication that can be used to do positive things during the recovery period to rebuild their lives.”

    The trade group that represents the clinics, which must be certified and accredited to qualify as OTPs, says that permanently loosening the rules is misguided and that lax oversight of patients by doctors helped created the opioid epidemic in the first place.

    The American Association for the Treatment of Opioid Dependence, or AATOD, is the trade group that represents more than 1,800 OTP facilities across the country. 

    Mark W. Parrino, the association’s president,  said he is adamantly opposed to allowing non-OTP doctors to prescribe methadone. He doesn’t trust doctors, he said.

    “We have reason. It’s not because we’re paranoid,” Parrino said. 

    Parrino blames doctors’ over-prescription of opioids, including methadone, in the ’90s and early 2000s to treat pain for the current crisis.

    “We think there’s a place for doctors, especially those working with OTPs, but, yes, frankly, to go back to the era of methadone mortality” is not acceptable, he said, referring to the period earlier this century when methadone overdoses spiked.

    Markey charges the clinics are just trying to protect their business interests, which he calls a “methadone monopoly.”

    “Their lobbyists want to bottleneck access clinics to increase profits,” Markey said in an interview. “Recovery is hard. We don’t need to make it any harder.”

    The House version of the legislation was folded into a larger mental health bill that overwhelmingly passed in June with 402 votes, but it has yet to be brought up for a consideration in the Senate. The bill has at least some bipartisan support in the Senate. Sens. Rand Paul (R-Ky.) and Mike Braun (R-Ind.) are co-sponsors.

    The legislation’s supporters are looking to attach to it a must-pass bill such as a year-end spending bill or the annual defense policy bill.

    Markey said the biggest impediment to doing so is the lobbying campaign being carried out by Parrino’s group.

    Drug overdoses have increased for the past two decades, with deaths in 2021 surpassing the previous record in 2020 with most of the deaths coming from fentanyl. (Our colleagues Julie Vitkovskaya and Courtney Kan have an excellent explainer on fentanyl.)

    Advocates for expanding access to methadone say studies that AATOD is using to undermine the legislation dealt only with methadone treatment for pain, not for addiction recovery, and that the doctors prescribing treatment would have to obtain the highest addiction treatment certification.

    Zac Talbott, president of the National Alliance for Medication Assisted Recovery, runs an opioid treatment facility in eastern Tennessee. He said he finds it a burden on some patients deep into their recovery to rely on OTP services.  

    “Patients who have benefited from OTP that no longer need the services, they should have choice,” Talbott said. “Stabilized patients deserve choices, and this would allow them that.”

    Dems under pressure on assault weapons ban

    As lawmakers hustle to avert a rail strike and keep the government funded, Democrats are still under pressure to take up long-shot legislation before they lose their House majority in January.

    March for Our Lives, Brady, Guns Down America and several other anti-gun-violence groups are sending a letter to Senate Majority Leader Charles E. Schumer (D-N.Y.) today urging him to bring the assault weapons ban legislation that passed the House in July up for a vote in the Senate. They’re making the push even though the bill lacks the 60 votes needed to overcome a Republican filibuster.

    “Look, if we don’t hold the vote, then the votes certainly aren’t there,” said Igor Volsky, Guns Down America’s executive director.

    “Part of our push here is to signal that the days of making rhetorical promises and not acting are over,” he added.

    Other gun-control groups are holding off their efforts until it’s clear that such legislation has the votes to pass.

    “We’re focused on bolstering our gun-sense majority in the Senate and reelecting Senator Warnock next week,” Stacey Radnor, a spokeswoman for Everytown for Gun Safety, the gun-control group backed by former New York mayor Mike Bloomberg, wrote in an email to The Early. “We also support legislation to regulate assault weapons and look forward to bringing it to the floor as soon as it secures enough votes for passage.”

    Looming rail strike: Will the Senate reach an agreement to vote on the legislation to prevent a rail strike? The House passed it Wednesday, sending it to the Senate, where Republicans are haggling over how to proceed so that it can be passed quickly, without all the procedural machinations. 

    Republicans are a bit all over the place on the issue. A couple say the workers should have sick leave, many say President Biden shouldn’t intervene, and others support moving quickly. 

    One proposed Republican amendment would extend the deadline into the new year. Sen. Bernie Sanders (I-Vt.) still wants his amendment that would provide the workers with seven paid sick days, too. 

    To try and help push the legislation over the finish line, Labor Secretary Marty Walsh and Transportation Secretary Pete Buttigieg will attend Senate Democrats’ policy lunch today.

    House Democrats’ leadership elections: House Democrats will continue their leadership elections today. They’ll vote for the new No. 4 position — assistant minority leader — which is now a contested race after Rep. David N. Cicilline (D-R.I.) announced that he would challenge Rep. James E. Clyburn (D-S.C.). Cicilline, who is gay, says there should be LGBTQ representation in the top rungs of leadership, but it’s highly unlikely he’ll beat Clyburn.

    Probing the collapse of FTX: The congressional response to the fall of cryptocurrency giant FTX kicks off today with a hearing on the matter. Commodity Futures Trading Commission (CFTC) Chairman Rostin Behnam will appear before the Senate Agriculture Committee.

    • 👀Reminder: Former FTX chief executive Sam Bankman-Fried and former FTX Digital Markets CEO Ryan Salame gave tens of thousands of dollars in campaign contributions to lawmakers on the committee — the same committee tasked with investigating its collapse.

    Here’s how federal judges think about diversity in hiring law clerks

    New: According to an article published online Wednesday, the nation’s top appeals court judges consider race and gender when evaluating applicants for prestigious one-year clerkships — a crucial steppingstone to obtaining a Supreme Court clerkship and advancing a career in appellate law, our colleague Ann Marimow reports.

    Of the 50 federal judges interviewed about their hiring practices for the article, “many reported difficulty hiring Black and Latino clerks,” Ann writes. “Those with the most success hiring people of color took steps to broaden their applicant pool and to consider indicators of talent beyond law school rank and grades. Black judges, the study shows, are particularly successful in recruiting and hiring Black clerks; they comprised less than one-eighth of all active appeals court judges at the time of the study, but accounted for more than half of the Black law clerks working in those courts.”

    • Here’s what one Black judge told the authors of the study: “I’ve seen a broad range of talent. … I don’t care where students went to school. You have to do your homework and dig underneath the transcript, figure out the curve, look beneath the law review editor titles. I drill deeper. … There’s no monopoly over brains or qualifications; it’s a question of opportunity.”

    Long story short: “Diversity among judges affects diversity among clerks,” the authors wrote.

    As Theo and Tobi reported last month, diversity is scarce throughout the entire appellate bar. The elite group of lawyers who argue before the Supreme Court justices remains mostly White and male, as well as the lawyers who clerk for them. When asked about the lack of diversity among clerks during a 2009 congressional budget hearing, Justice Clarence Thomas told lawmakers: “We receive what the law schools prepare.”

    Where the House GOP Impeachment 10’s aides are landing

    First in The Early: Jordan Evich, the deputy chief of staff to Rep. Jaime Herrera Beutler (R-Wash.), is heading to K Street.

    Evich will lead the appropriations practice at the lobbying firm Monument Advocacy.

    Herrera Beutler is one of the 10 House Republicans who last year voted to impeach President Donald Trump. Eight of them are leaving Congress — four of them didn’t run for reelection, while Reps. Liz Cheney (R-Wyo.), Peter Meijer (R-Mich.), Tom Rice (R-S.C.) and Herrera Beutler lost their primaries — meaning their staffers will need new jobs.

    Evich isn’t the only one to land on K Street. Maggie Woodin, Meijer’s legislative director, recently left for the U.S. Chamber of Commerce.

    Thanks for reading. You can also follow us on Twitter: @LACaldwellDC and @theodoricmeyer.

    Ending telehealth cuts off a vital tool against opioid addiction

    Ending telehealth cuts off a vital tool against opioid addiction

    The opioid disaster is a countrywide tragedy. In the final 12 months, about 108,000 Us citizens have been lost to drug overdoses, the most on report, with about 3-quarters of all those premature fatalities involving opioids. Shockingly, illicit medication are now the number a single killer of People in between ages 18 and 45 — a lot more than firearms, car incidents and COVID-19 — and a significant contributing element to a sharp decrease in U.S. life expectancy. 

    As lousy as the disaster has been, it has the opportunity to mature even even worse as a number of essential resources in the fight versus drug addiction and abuse are established to expire in the coming months. Between these is the growth of telemedicine to address all those struggling from opioid use disorder (OUD).   

    At the onset of the COVID-19 pandemic, the U.S. Department of Overall health and Human Providers (HHS) and Drug Enforcement Administration (DEA) loosened restrictions to enable DEA-registered practitioners to problem medication-assisted remedy (MAT) to individuals with out very first conducting an in-individual analysis. These medicines, together with buprenorphine and methadone, are thought of the “gold standard” in treating OUD, with much greater results than other therapy alternatives. 

    The government at first granted this exemption to advertise social distancing and assure continuity of treatment for the duration of the unprecedented COVID-19 overall health unexpected emergency, but it had the added benefit of lowering the stigma and other obstacles to acquiring in-particular person remedy, especially for susceptible and hard-to-get to populations that often lack access to top quality health care.   

    Despite the fact that the influence of this transform is difficult to quantify, it has undoubtedly saved lives. Without a doubt, recent studies have shown clients having buprenorphine are around 60 per cent much less probable to put up with a lethal overdose than those people not using treatment for OUD, and that prescribing buprenorphine by means of telemedicine is at the very least as productive, and occasionally much more effective, at maintaining clients in treatment method.   

    Sadly, the telemedicine exemption will lapse at the end of the COVID-19 community wellbeing emergency declaration, at this time established to expire on Oct 2022, at which place new and present individuals will eliminate obtain to these possibly everyday living-preserving companies. While the Biden administration is likely to prolong the general public well being crisis at the very least till January, that nevertheless only leaves precious couple months for the notoriously gradual wheels of forms to turn.   

    The clock is ticking, and when the DEA has signaled its intention to make these regulations long term, it is unclear irrespective of whether they will be ready to meet the looming deadline. And while some users of Congress have urged the DEA to fulfill this pledge “as before long as possible,” they too need to be organized to act with new laws.   

    Telemedicine is not without having risks, and some practitioners have expressed valid issues that distant health care may well guide to amplified misuse or diversion of MAT from its meant reason. On the other hand, with the U.S. drug disaster reaching genuinely epic proportions, the gains of bigger entry to cure appreciably outweigh any possible hurt. A recent review of in excess of 500 opioid-included deaths found only one particular was solely attributable to buprenorphine. Another discovered that enhanced use of telemedicine all through the pandemic did not direct to an raise in misuse or overdose of methadone.   

    And while some claim prescribing medication-assisted therapy just “substitutes one opioid for an additional,” the truth of the matter is that medically-recommended buprenorphine is much fewer unsafe than illicitly created prescription drugs like fentanyl, a strong synthetic opioid far more than 50 occasions much better than heroin. Definitely, both equally have the probable for misuse, but if prescription MAT is a one lit match, illicit fentanyl is a raging four-alarm fire. 

    The use of MAT is considerably preferable to illicit prescription drugs located on the web or on the road, and telemedicine is an important stage to improving accessibility to remedy and serving to to unwind the Gordian knot of the U.S. opioid disaster. The target of drug remedy packages ought to be to eradicate drug use, but for many suffering from OUD, recovery is an iterative process, and quitting may possibly not be attainable, at the very least not appropriate absent. In the meantime, prescription drugs like buprenorphine and methadone can assist curb withdrawal signs and symptoms and cravings whilst significantly minimizing the likelihood of overdoses. 

    As the COVID-19 community health and fitness emergency attracts to a shut, it is essential policymakers transfer quickly to make these powerful, commonsense alterations long lasting so health care experts can continue on to reach those people most in need. The danger of inaction is just much too excellent. 

    Jim Crotty is an associate vice president at The Cohen Team, a strategic advisory company in Washington, D.C. He is the former deputy main of personnel at the U.S. Drug Enforcement Administration. The sights expressed are the author’s individual.

    Johnston County residents weigh in on opioid settlement plan

    Johnston County residents weigh in on opioid settlement plan

    A social employee who missing her brother to suicide in the course of energetic dependancy.

    A spouse and children whose daughter died of a fentanyl overdose right after cheerleading led to a drug behavior.

    A mom who experienced just pushed her son to the airport to start off habit procedure for the fifth time.

    These voices were amid the community customers who spoke at a assembly of the Johnston County Opioid Activity Pressure on Tuesday.

    Concerning now and 2038, Johnston County will receive above $8 million in countrywide opioid settlement funding. As the county general public health division makes a paying out strategy, it’s bringing people struggling with addiction, and their cherished types, to the desk.

    NC suspected overdose deaths

    To get started expending settlement bucks straight away, North Carolina counties need to perform within just a checklist of methods demonstrated to have a substantial impression on abating opioid use.

    Any county that chooses these pre-authorized ambitions will undertake a related brainstorming course of action. Wake County will maintain its personal general public conference Aug. 2.

    Johnston County proven an opioid endeavor pressure in 2017 as several residents faced habit. However, overdoses and deaths continue to climb, in particular as fentanyl gets to be much more present in heroin profits.

    The condition noted this week there ended up 326 suspected overdose deaths in June, in comparison to 288 in June 2021. All told, suspected overdose deaths ended up up 9{35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} concerning this January and June compared to the identical period of time previous year.

    In Johnston County, emergency health-related assistance staff administered the overdose-reversal drug Naloxone to 198 people last year. They’re presently up to 172 doses considering that January.

    Now, county commissioners are searching at in which the shortlist tactics overlap with existing courses like Naloxone distribution, and exactly where methods need to be built from scratch.

    The county’s prepare would set $35,000 a 12 months towards sponsoring small-expression detox courses for 100 inhabitants for each yr, explained wellbeing office director Marilyn Pearson.

    It would also area 5,000 doses of Naloxone — also acknowledged by the brand title Narcan — in educational institutions, libraries, fire stations and other local community facilities.

    Lengthy-phrase objectives would contain assembling a post-overdose medical reaction staff and instruction 3 to 5 peer support employees a calendar year, which could also deliver employment for all those recovering from addiction.

    “We’re likely to fulfill folks where they are,” Pearson said, “and then consider to figure out, more than the very long term, what we can do to enable people today in Johnston County.”

    Extensive-phrase rehabilitation

    People mainly agreed with the county’s precedence listing. Having said that, many required far more money for new extensive-term treatment method selections.

    Johnston County does not have a extensive-phrase rehabilitation facility for recovering opioid end users.

    Casey White, whose brother killed himself through active opioid addiction, explained not acquiring these kinds of a center has affected her friends “from infancy all the way to adulthood.”

    When an opioid person chooses to search for out a rehab application, it’s essential to preserve that momentum by locating a single correct absent, claimed Adam Denning, director of Twelve Stones, a faith-centered recovery group in Angier.

    Some religion-primarily based teams, together with Restoration Alive!, by now provide housing and vocational instruction to Johnston County residents recovering from habit.

    But for the most aspect, obtaining prolonged-phrase treatment indicates going outside the county, and in some cases ready three or 4 days for intake paperwork.

    “When anyone is ready, they’re completely ready right then, and we require to act on that,” mentioned JoCo Angels vice president Danette Jernigan.

    This means that people today coming out of a detoxing interval frequently have nowhere to go, specifically when they are uninsured, Jernigan mentioned.

    Restoration housing is also a significant resource for recovering persons who are formerly incarcerated, stated White. As the only member of her relatives who has hardly ever been arrested, she reported she’s observed relatives leave jail and falter without the need of a safety internet.

    “The quantity of people today who are in this county who have nowhere to go as soon as they are released from jail is astronomical,” White reported. “So they are likely back again to the exact individuals who they utilised with, and now they are back again in that quite same cycle.”

    Early Intervention

    Pearson reported the county options to emphasize additional early-intervention techniques. Citizens were on board but mentioned to be efficient, avoidance packages ought to focus on youthful men and women and collaborate with colleges.

    Lots of religion-dependent recovery organizations all-around Johnston County host opioid dependancy support groups. One, at Restoration Alive!, offers little ones and teens a place to discuss about their home life.

    Local community associates also want to destigmatize recovery for young users and to address fundamental psychological health and fitness concerns.

    Jernigan encouraged her daughter to show up at assist teams when she was struggling with a Xanax addiction that turned into a heroin addiction. Dakota Jernigan, who died of a fentanyl overdose in 2019, had advised her mother she felt alienated at conferences.

    “It was just a bunch of outdated gentlemen,” Jernigan recalled her daughter saying.

    Jernigan and many other community members discussed teaching lecturers to support college students who are battling dependancy, or whose people are touched by addiction.

    Opioid use is expanding at South Johnston and West Johnston significant faculties, explained JoCo Angels co-president Kelley Blas.

    “If we imagine that this habit things begins in superior college and after, it is not, “ said Jernigan.

    Carol Johnson, whose daughter was a cheerleader prior to she overdosed, explained recent early intervention supports don’t kick in right until young folks are actively making use of opioids.

    Like Dakota Jernigan, Johnson stated her daughter appeared really well-adjusted, and her school sports seemed like a healthful natural environment,ahead of her addiction became obvious.

    The county’s priority framework dedicates way too a lot of resources toward figuring out how to support recovering addicts, Johnson stated. Rather, she urged the county to double down on stopping new opioid use in vulnerable populations.

    “We just need to prevent it from taking place to start out with,” Johnson informed The News & Observer right after the meeting. “Parents, academics, group members, are all turning a blind eye to it and ready for some thing to happen.”

    What’s subsequent

    Customers of the community health and fitness section will compile Tuesday’s suggestions and include things like it in the ultimate draft of their paying program. County commissioners will vote on the plan at an future assembly.

    Wake County’s community comments meeting will be held at the Wake County Commons Constructing, 4011 Carya Drive, from 11 a.m. to 2 p.m. Tuesday, Aug. 2. People can go to practically or in person and can signal up on the net at www.wakegov.com/countrywide-opioid-settlement

    This tale was initially posted July 20, 2022 9:28 AM.

    Connected stories from Raleigh News & Observer